<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02035839</url>
  </required_header>
  <id_info>
    <org_study_id>FROST Trial</org_study_id>
    <nct_id>NCT02035839</nct_id>
  </id_info>
  <brief_title>Finding the Optimal Cooling tempeRature After Out-of-HoSpiTal Cardiac Arrest</brief_title>
  <acronym>FROST</acronym>
  <official_title>A Pilot Multicenter Randomized Trial on the Effectiveness of Different Levels of Cooling in Comatose Survivors of Out-of-hospital Cardiac Arrest.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ZOLL Circulation, Inc., USA</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Instituto de Investigación Hospital Universitario La Paz</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>ZOLL Circulation, Inc., USA</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To assess the fraction of subjects surviving with good neurological outcome at 90 days for 3
      different levels of hypothermia, in comatose survivors from out-of-hospital cardiac arrest.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Actual">April 2016</completion_date>
  <primary_completion_date type="Actual">April 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Fraction of subjects surviving with good neurologic outcome(modified Rankin Score (mRS) ≤ 3) at 90 days after out-of-hospital cardiac arrest.</measure>
    <time_frame>at 90 days after out-of-hospital cardiac arrest</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Treatment Success: 1. proportion of subjects that can be therapeutically cooled to randomly allocated target temperature ±0.3°C (as measured by the temperature probe)</measure>
    <time_frame>24 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Treatment Success: 2. proportion of time at randomly allocated target temperature ±0.3°C during first 24 hours after initiation of induction of hypothermia</measure>
    <time_frame>24 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Treatment Success: 3. time to randomly allocated target temperature, from call to 911, sustained restoration of circulation and initiation of induction of hypothermia</measure>
    <time_frame>26 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Treatment Success: 4. rate of cooling in °C per hour</measure>
    <time_frame>Per hour</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Treatment Success: 5. rate of rewarming in °C per hour</measure>
    <time_frame>Per hour</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Outcomes: 1.Favorable neurologic status at 90 days (i.e. mRS &lt; 3) measured as proportion</measure>
    <time_frame>90 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Outcomes: 2.Time to first detected mRS ≤3 (i.e. Kaplan Meier curve)</measure>
    <time_frame>90 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Outcomes: 3.Robust neurologic status at 90 days (i.e. mRS &lt; 2) measured as proportion</measure>
    <time_frame>90 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Outcomes: 4. Time to first detected mRS ≤2 (i.e. Kaplan Meier curve)</measure>
    <time_frame>90 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Outcomes: 5. Survival at 90 days measured as proportion</measure>
    <time_frame>90 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Outcomes: 6. Cumulative incidence of survival at 90 days (i.e. Kaplan Meier curve)</measure>
    <time_frame>90 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Outcomes: 7. ICU-free survival within 90 days measured in days</measure>
    <time_frame>90 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Outcomes: 8. Hospital-free survival within 90 days measured in days</measure>
    <time_frame>90 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Outcomes: 9. Adverse events a. Device related b. Procedure related</measure>
    <time_frame>90 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subgroup analysis</measure>
    <time_frame>1 year</time_frame>
    <description>A priori plan to assess heterogeneity of effect among specific subgroups of special interest as well as to assess the consistency of treatment effect among different subpopulations defined by each of multiple baseline characteristics of the patients. These will be assessed by repeating the primary analysis in the subgroups defined below, using interaction terms.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subgroups of Special Interest Age of Patients</measure>
    <time_frame>Duration of the trial</time_frame>
    <description>18 to 65 years; or (ii) &gt; 65 years.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Timings of initiation of hypothermia</measure>
    <time_frame>&lt;4 hours of restoration of spontaneous circulation; or &gt; 4 hours</time_frame>
    <description>(ii) &gt; 65 years.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Gender</measure>
    <time_frame>Male or Female</time_frame>
    <description>Subgroups to assess Consistency of Effect</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Observational status of arrest</measure>
    <time_frame>Witnessed by EMS; Witnessed by bystanders</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Location of cardiac arrest</measure>
    <time_frame>Public;Home; or Group residence (e.g. nursing home)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bystander CPR status:</measure>
    <time_frame>Performed; or Not performed.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>AED status:</measure>
    <time_frame>Applied by layperson;Applied by EMS provider;Not applied</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Response time interval from call to initiation of CPR by EMS, among witnessed arrests:</measure>
    <time_frame>&lt; 10 minutes;&gt; 10 minutes.</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">150</enrollment>
  <condition>Out-Of-Hospital Cardiac Arrest</condition>
  <arm_group>
    <arm_group_label>Target Temperature Management of 34°C</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>In hospital target temperature management to achieve core body temperature of 34°C for 24 hours.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Target Temperature Management of 32°C</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>In hospital target temperature management to achieve core body temperature of 32°C for 24 hours.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Target Temperature Management of 33°C</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>In hospital target temperature management to achieve core body temperature of 33°C for 24 hours.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Target Temperature Management of 34°C</intervention_name>
    <description>In hospital target temperature management to achieve core body temperature of 34°C for 24 hours.</description>
    <arm_group_label>Target Temperature Management of 34°C</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Target Temperature Management of 32°C</intervention_name>
    <description>In hospital target temperature management to achieve core body temperature of 32°C for 24 hours.</description>
    <arm_group_label>Target Temperature Management of 32°C</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Target Temperature Management of 33°C</intervention_name>
    <description>In hospital target temperature management to achieve core body temperature of 33°C for 24 hours.</description>
    <arm_group_label>Target Temperature Management of 33°C</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Signed informed consent (obtained from their legal representative)

          -  18 years of age or older and less than 80 years old.

          -  Witnessed OHCA of presumed cardiac cause

          -  Sustained ROSC (when chest compressions have not been required for 20 consecutive
             minutes and signs of circulation persist)

          -  Initial shockable cardiac rhythm (documented by ECG or AED)

          -  Interval from collapse to advance life support &lt; 20 minutes

          -  Interval from collapse to ROSC &lt; 60 minutes

          -  Lack of meaningful response to verbal commands upon arrival to hospital after
             suffering non-traumatic cardiac arrest in an out-of-hospital setting

          -  Systolic blood pressure of &gt;90 maintained for a least 30 minutes post-ROSC without
             pressors, or with a stable dose of pressors

        Exclusion Criteria:

          -  Traumatic cardiac arrest

          -  Toxicological etiology

          -  Known or suspected pregnancy

          -  Do Not Attempt to Resuscitate order in force

          -  Unwitnessed arrest

          -  In-Hospital arrest

          -  Anatomy, previous surgery or disease state contraindicating femoral venous access

          -  Received neuromuscular blocking agents prior to assessing level of consciousness
             following ROSC

          -  Neurological evaluation insufficient/incomplete after ROSC but prior to randomization.

          -  Body core temperature &lt; 34ºC at randomization

          -  Current Inferior Vena Cava (IVC) filter

          -  Known history of acute neurological illness or severe functional disabilities prior to
             arrest (e.g., seizures, traumatic brain injury, increased intracranial pressures,
             intra-cerebral hemorrhage, etc).

          -  Known hypersensitivity to hypothermia including a history of Raynaud's disease

          -  Suspected or confirmed acute intracranial bleeding

          -  Suspected or confirmed acute stroke

          -  Terminal illness or life expectancy of less than 3 months prior to arrest

          -  Currently enrolled in another investigational new drug or device trial that has not
             completed the primary endpoint or that clinically interferes with this Trial's
             endpoints (For the purpose of this protocol, subjects involved in extended follow-up
             trials or registries for products that are currently commercially available are not
             considered enrolled in an investigational trial).

          -  Transferred from a non-participating hospital.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Prof. Esteban Lopez-de-Sa, M.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitario La Paz. Planta</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Charité - Universitätsmedizin Berlin</name>
      <address>
        <city>Berlin</city>
        <zip>13353</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario La Paz. Planta</name>
      <address>
        <city>Madrid</city>
        <state>Pso. de la castellana</state>
        <zip>26128046</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>H. Principe de Asturias</name>
      <address>
        <city>Alcala de Henares</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Germans Trias i Pujol University Hospital</name>
      <address>
        <city>Badalona</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital de Sant Pau</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de Bellvitge</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitari de Girona Doctor Josep Trueta</name>
      <address>
        <city>Girona</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital General Universitario Gregorio Marañón.</name>
      <address>
        <city>Madrid</city>
        <zip>28007</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital San Carlos</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de Salamanca</name>
      <address>
        <city>Salamanca</city>
        <zip>88-182, 37007</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de Canarias</name>
      <address>
        <city>Santa Cruz de Tenerife</city>
        <zip>38320</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>H. University of Santiago de Compostela</name>
      <address>
        <city>Santiago de Compostela</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitarion Virgen de la Macarena</name>
      <address>
        <city>Sevilla</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Araba Txagorritxu</name>
      <address>
        <city>Vitoria</city>
        <zip>01009</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
    <country>Spain</country>
  </location_countries>
  <removed_countries>
    <country>Austria</country>
    <country>Italy</country>
    <country>Portugal</country>
  </removed_countries>
  <link>
    <url>http://circ.ahajournals.org/</url>
    <description>Pilot trial comparing 2 levels of target temperature. Circulation. 2012;126:2826-2833</description>
  </link>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 27, 2013</study_first_submitted>
  <study_first_submitted_qc>January 10, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 14, 2014</study_first_posted>
  <last_update_submitted>May 23, 2017</last_update_submitted>
  <last_update_submitted_qc>May 23, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 30, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Target Temperature Management</keyword>
  <keyword>Cooling comatose survivors from OHCA</keyword>
  <keyword>Good neurological outcome at modified Rankin Score (mRS) ≤ 3</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Arrest</mesh_term>
    <mesh_term>Out-of-Hospital Cardiac Arrest</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

